The galectin-3 Inhibitors project tests a small molecule under development for peripheral indications for treating neuroinflammation in an Alzheimer’s mouse model.
Accelerating a cure for 100M Long COVID patients.
Relieva is redefining therapeutic innovation through the world’s first proprietary cannabis and hemp pre-roll blend engineered for targeted pain relief.
ValleyDAO is a decentralized platform revolutionizing funding and translation for synthetic biology research to combat climate change.
The first human trial that will tell you - with blood - which training actually grows your brain.
Neuron-Gale
Long Covid Labs
Relieva
ValleyDAO
Holi
0.30%
0.44%
